how the pharmaceutical industry can benefit from the ... · akqdip_141023_01_dip_how the...
TRANSCRIPT
How the pharmaceutical industry can benefit from the automotive sector
PDA Europe – Parenterals 2014
D. Pfitzer, Porsche Consulting GmbH
Munich, November 4 - 5, 2014
Pharmaceuticals are not exactly automotive …
Source: Photos: Istockphoto; Porsche AG
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 2
… but we are all striving for the same operational excellence
Operational excellence is the desire and ability of an organization and its employees to consistently deliver top performance, time and again.
Porsche Consulting 3
Source: Porsche Consulting; photo: Porsche AG
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx
1992 was the start of a new era for Porsche
Porsche Consulting Source: Porsche Consulting, Porsche AG; photo: Porsche AG AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 4
Survey of the top 20 pharmaceutical companies: None of the companies surveyed focused on operational excellence before the year 2000
Source: Porsche Consulting, Study 2013; photo: Istockphoto AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 5
In what year did you start structured programs to achieve operational excellence? 44%
33%
0%0%
1995 - 2000 > 2010
23%
2006 - 2010 2001 - 2005 < 1995
Implementation from 2000
Porsche Consulting
Porsche has rigorously implemented operational excellence since 1992
Source: Porsche Consulting, Porsche AG; photo: Porsche AG AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 6
The key to a sustainable increase in productivity lies in the combination of continuous improvement and new concepts
-74% Model change 964 à 993
Model change 993 à 996
Model change 996 à 997
Model change 997 à 991
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 7
Source: Porsche Consulting, Porsche AG; photo: Porsche AG
50%
100%
0%
25%
75%
Production time Porsche 911
Year 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 91 09 10 11 12 13
Continuous improvement New concept
OEEs are an indicator of high productivity: It is generally known that OEEs are higher in the automotive sector – but why?
90%
40% AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 8
* OEE = Utilization rate in % (machine utilization = 100%) x Performance coefficient in % x First-time-right rate in %
Source: Porsche Consulting; photo: Porsche AG, Fotolia
At Porsche, cross-series assembly concepts are one of the reasons for the high OEEs
Source: Porsche Consulting, Porsche AG; photo: Porsche AG AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 9
Result
Imple-mentation
Customer relevance
§ The same modules are used in different products
§Modules are assembled in the same way
§The focus is on assembly processes and thus on reducing production times
§ Individual design and distinguishing characteristics "in the rear view mirror"
To summarize: 6% increase in productivity year over year due to operational excellence
* Porsche Zwischenholding GmbH ** Calendar year 2010 Source: Porsche AG, Annual Report
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 10
89.123
105.162101.844102.602
73.284
55.78248.815
45.119
38.00732.390
20.79119.34815.082
23.23427.525
165 .808
17.50215.30713.15912.72212.65212.20211.57111.38411.87811.66810.69910.1439.7529.3208.7128.1517.9597.1076.8476.9708.4319.005
19.456
0
20.000
40.000
60.000
80.000
100.000
120.000
140.000
160.000
180.000
2013 2012
151.999
2011
127.793
2010**
95.564
09/10* 08/09
76.739
07/08 06/07 05/06 04/05
90.954
03/04
81.531
02/03 01/02
55.050
00/01 99/00 98/99 97/98 96/97 95/96
20.242
94/95 93/94 92/93
7.133
91/92 90/91
Employees Production
In the pharmaceutical industry also, expectations from introducing of operational excellence have been met – overachievement, however, is rarely the case
Source: Porsche Consulting, Study 2013; photo: Fotolia AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 11
0%
0%
11%
89%
Results not recorded/evaluated
Expectations not met
Expectations exceeded
Expectations met
How satisfied are you with the results achieved?
Porsche has defined an annual increase in productivity of 6% as one of its goals – the greatest contribution now comes from outside Production*
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 12
28% of 100% potential through
operational excellence
72% of
100% potential through operational excellence
Development 28% Sales 23% Finance 13% Personnel 8%
* FY 07/08 - 09/10 Source: Porsche AG, R. Kallenberg, October 2010; photo: Fotolia, Porsche AG
What potentials have you already achieved/planned through operational excellence?
Looking ahead: 75% of pharmaceutical companies strive for an increase in productivity of 5% to 10% within a period of 2 years
Source: Porsche Consulting, Study 2013; photo: Fotolia AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 13
0%
75%
25%
0%
> 20% 11 – 20 % 5 – 10 % < 5%
25%
50%
25%
0%
In the past 2 years
In the next 2 years
Increase in productivity
Porsche has optimized its supply chain – transparency makes the greatest contribution to efficiency and inventory reductions
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 14
Order management
Program planning
Resource planning
Demand
Capacity/ restrictions
Balance between capacity and demand
Customer
Order book
Local markets/sales
Model & option planning
Factories Suppliers
Source: Porsche Consulting, Porsche AG
By implementing a new logistics concept, Porsche further reduced its inventory at the Leipzig plant
Porsche Consulting Evaluation of Porsche Leipzig October 2012 (6-monthly average goods receipt to installation location) Source: Porsche Consulting; photo: Porsche AG
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 15
Example of internal logistics
Source: Porsche Consulting, Porsche AG
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 16
Example of process chain for assembly part from logistics hub to installation …
"That's quite a logistical feat: I don't know of any other factory in the world where the principles of lean production have been implemented as consistently as here in Leipzig"
Dr. Michael Macht, former production member of the Board of Management of Volkswagen AG
Hub Receiving area
Staging Picking
Picking in the warehouse
Delivery at the line
Installation in the vehicle
09:15 14:15 14:20 14:30 09:10 06:00
Inventories are at < 1 days range with 22% lower logistics costs
* Evaluation of Porsche Leipzig October 2012 (6-monthly average goods receipt to installation location) Source: Porsche Consulting
-22%
Internal logistics
Transport
Result NLC
Target value for planning
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 17
Inventory Costs
-62%
Actual*
< 1 day
Start (2007)
2.1
In the pharmaceutical industry, there are high inventory coverages in API, bulk and packaged finished products
Source: Porsche Consulting, Study 2013; photo: Istockphoto AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 18
0%
25%
0%
38%38%
< 50 days
> 200 days
151 - 200 days
101 - 150 days
50 - 100 days
13%25%
13%
38%
13%
25%
50%
0%13%13%
API
Bulk
Packaged finished products
How high are the average inventory coverages in your company?
Optimization of the end-to-end supply chain is also one of the most important starting points for increasing efficiency in the pharmaceutical industry in the future
* Miscellaneous: Standardization, quality improvements in production and sales Source: Porsche Consulting, Study 2013; photo: Istockphoto, Panthermedia, Fotolia
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 19
22%
33%
67%
89%
Outsourcing
Miscellaneous*
Supplier management/ integration
Optimizing the end-to-end supply chain
On what areas will you concentrate in the next 2 years to counter increasing cost pressures? (multiple answers possible)
Due to the low real net output ratio, professional supplier management is an important success factor at Porsche – the complexity is enormous
§Approx. 10,000 individual parts §Approx. 3,000 item numbers §Approx. 1,000 purchase items §Approx. 300 suppliers per vehicle §Approx. 150 key components over €20
Source: Porsche Consulting empirical values (average values across several OEMs); photo: Porsche AG AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 20
Example: The steering wheel is one of 150 assemblies
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 21
Source: Porsche Consulting, Porsche AG; photo: Porsche AG
The steering wheel can again be differentiated in seven sub-assemblies …
Base carrier
Crest
Airbag
Trim
Switches
Wood/ carbon
Leather covering
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 22
Source: Porsche Consulting, Porsche AG; photo: Porsche AG
… which are procured through an international supplier network
Installation
Installation
Assembly
Crest
Leather
Blind cover Finish
Sports cover Leather covering
Molding, foaming Leather covering Basic cover
Y-shaped trim Magnetic ring Light guide Scroll wheel Circuit board Assembly
Veneer PU milling Veneering Covering Painting Polishing Assembly
Finish
Airbag Cartridge Assembly
Cover Button Paddle Finish
Container
Switch mat
Leather covering
Role of Porsche
§ Specification
§ Integration
§Quality management
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 23
Source: Porsche Consulting, Porsche AG; photo: Porsche AG
Porsche maintains long-term supplier partnerships – already in the early stages of development
Source: Porsche Consulting, Porsche AG; photo: Porsche AG AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 24
Product development phase
Supplier assessment
Supplier development in PDP
Program readiness Task force
Supplier optimization program
Series phase
Support for concept
development
Preventative supplier
integration
Preventative start-up assurance
(purchased part mgt.)
Reactive start-up assurance
(purchased part mgt.)
POLE- position
Supplier management and integration will play an important role in the pharmaceutical industry in the future
* e.g. replenishment time, weekly capacities, delivery accuracy, quality Source: Porsche Consulting, Study 2013; photo: PantherMedia
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 25
What tools do you use or plan to use in the area of supplier management? (multiple answers possible)
A suppliers B suppliers C suppliers
2244
3311 2211
11
56
2233
0
33
11
67
11
44
0
44
Present Planned
11
67
2222 1122
Continuous assessment of supplier performance
Transparent costing (open book)
Target agreements*
Supplier assessment
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 26
Can Porsche do everything better?
No. Porsche just focuses better on the core competencies
What does "core competence" actually mean?
Prevents the potential for imitation
Allows access to markets
Differentiation
Cannot be imitated
Customer benefits
Diversification
Contribution to customer benefits
Differentiates from the competition
Porsche Consulting Source: Prahalad/Hamel “Core competencies of the organization”, photo: Fotolia AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 27
Example: At Porsche, the focus is on "driving dynamics" as a core competence
Fast follower
First mover
Late follower
Non follower
§Valve drive control
§Braking technology
§Turbo technology
§Communication systems
§Comfort equipment
§Hydrogen technology
§Best in Class
§Best in Class
§Best in Class
§State-of-the-art
§State-of-the-art
§–
Market strategy Objectives
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 28
Source: Porsche Consulting, Porsche AG; photo: Porsche AG
67% consider production as a core competence – although the companies surveyed were exclusively research-based pharmaceutical companies
* Miscellaneous: Pricing & access Source: Porsche Consulting, Study 2013; photo: Fotolia
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 29
What areas in your company do you view as core competencies? (multiple answers possible)
11%
89%
67%
33%
67%
56%
56%
89%
Miscellaneous*
Sales & Marketing
Manufacturing/ production
Licensing
Phases I - III
Phase 0
Preclinical phase
Research
And in production also, almost all production steps are declared as core competences
* Active pharmaceutical Ingredient ** Contract manufacturer (CMO) Source: Porsche Consulting, Study 2013; photo: Istockphoto
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 30
What areas within production do you view as core competencies? (multiple answers possible)
67%
67%
78%
89%
78%
Packaging of sterile products
Packaging of solids
Bulk/finished medicinal products
Sterile products
Bulk/finished medicinal products
Solids
API*/ active pharmaceutical
ingredients
Conclusion
Operational excellence is not industry-specific
No company has core competence in all areas – recognizing this fact extends the horizon
Porsche Consulting Source: Porsche Consulting; photo: Fotolia AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 31
Operational excellence does not happen by itself, but is a result of hard work
D. Pfitzer Tel.: 0170 911 3376 E-mail: [email protected]
AKQDIP_141023_01_DIP_How the pharmaceutical industry can benefit from the automotive sector.pptx 32
Are you interested in
the study?